4.6 Article

mRNA vaccines induce rapid antibody responses in mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel et al.

Summary: The two vaccine candidates, BNT162b1 and BNT162b2, developed contain modified messenger RNA encoding immunogens derived from the spike glycoprotein of SARS-CoV-2. They have shown promising immune responses in mice and rhesus macaques, with ongoing phase I trials in Germany and the USA and a global phase II/III trial for BNT162b2.

NATURE (2021)

Review Immunology

HIV mRNA Vaccines-Progress and Future Paths

Zekun Mu et al.

Summary: mRNA-based vaccines introduce a new approach by relying on host cells to produce antigenic proteins, offering a potential platform for protection against various diseases including HIV. This review explores the challenges of developing vaccines for HIV and outlines a vaccination strategy based on the immunology of broadly neutralizing antibody development.

VACCINES (2021)

Review Biochemistry & Molecular Biology

Novel approaches for vaccine development

Makda S. Gebre et al.

Summary: Vaccines are crucial for global health, with traditional methods being successful in many cases but facing challenges such as persistent infections and emerging pathogens. Novel technologies like nucleic acid and viral vector vaccines have the potential to revolutionize vaccine development.
Article Virology

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays

Jingyou Yu et al.

Summary: The study outlines a method to generate a highly infectious SARS-CoV-2 pseudovirus for evaluating humoral immunity, antibody therapeutics, and vaccines. The SDCT13-based pseudovirus neutralization assay exhibits key characteristics including linearity, limit of detection, and assay precision. This assay is adaptable for emerging SARS-CoV-2 variants and crucial for the development of vaccines and immune-based therapeutics.

JOURNAL OF VIROLOGY (2021)

Article Immunology

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

Susanne Rauch et al.

Summary: mRNA technologies have shown clinical efficacy against COVID-19, with the CVnCoV vaccine demonstrating strong immune responses and protection against SARS-CoV-2 in preclinical studies. Overall, CVnCoV represents a potent and safe candidate for a COVID-19 vaccine.

NPJ VACCINES (2021)

Article Multidisciplinary Sciences

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Kizzmekia S. Corbett et al.

Summary: In nonhuman primates (NHPs), vaccination with mRNA-1273 induces dose-dependent antibody responses, leading to a significant reduction in viral replication post SARS-CoV-2 challenge. Replication of the virus correlates strongly with antibody levels and neutralizing activity, with lower levels required in the lower airway than in the upper airway. Passive transfer of mRNA-1273-induced IgG is sufficient to provide protection, indicating that humoral immune responses induced by mRNA-1273 vaccine are effective against SARS-CoV-2 in NHPs.

SCIENCE (2021)

Article Multidisciplinary Sciences

CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

Donata Hoffmann et al.

Summary: The study demonstrates that two spike encoding mRNA vaccines provide effective protection against the variants of concern B.1.351 and the ancestral strain BavPat1 of SARS-CoV-2, despite lower neutralizing antibody titers against B.1.351.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Victor J. Costela-Ruiz et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Lisa H. Tostanoski et al.

NATURE MEDICINE (2020)

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Immunology

New Vaccine Technologies to Combat Outbreak Situations

Susanne Rauch et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Pre-fusion structure of a human coronavirus spike protein

Robert N. Kirchdoerfer et al.

NATURE (2016)

Review Biochemistry & Molecular Biology

B cells responses and cytokine production are regulated by their immune microenvironment

Monica I. Vazquez et al.

CYTOKINE (2015)

Article Chemistry, Multidisciplinary

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Review Biochemistry & Molecular Biology

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

Satish L. Deshmane et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)